Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Revolution Medicines (RVMD) Current Leases: 2020-2024

Historic Current Leases for Revolution Medicines (RVMD) over the last 5 years, with Dec 2024 value amounting to $12.9 million.

  • Revolution Medicines' Current Leases rose 94.45% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year increase of 94.45%. This contributed to the annual value of $12.9 million for FY2024, which is 74.68% up from last year.
  • According to the latest figures from FY2024, Revolution Medicines' Current Leases is $12.9 million, which was up 74.68% from $7.4 million recorded in FY2023.
  • In the past 5 years, Revolution Medicines' Current Leases registered a high of $12.9 million during FY2024, and its lowest value of $3.7 million during FY2020.
  • Over the past 3 years, Revolution Medicines' median Current Leases value was $7.4 million (recorded in 2023), while the average stood at $9.0 million.
  • Data for Revolution Medicines' Current Leases shows a peak YoY skyrocketed of 74.68% (in 2024) over the last 5 years.
  • Revolution Medicines' Current Leases (Yearly) stood at $3.7 million in 2020, then soared by 69.23% to $6.2 million in 2021, then rose by 9.00% to $6.8 million in 2022, then rose by 8.80% to $7.4 million in 2023, then surged by 74.68% to $12.9 million in 2024.